- Home
- ACLS vs BHC Comparison
ACLS vs BHC Comparison
Compare ACLS & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- BHC
- Stock Information
- Founded
- ACLS 1995
- BHC N/A
- Country
- ACLS United States
- BHC Canada
- Employees
- ACLS N/A
- BHC N/A
- Industry
- ACLS Industrial Machinery/Components
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- BHC Health Care
- Exchange
- ACLS Nasdaq
- BHC Nasdaq
- Market Cap
- ACLS 2.8B
- BHC 3.0B
- IPO Year
- ACLS 2000
- BHC N/A
- Fundamental
- Price
- ACLS $69.88
- BHC $7.43
- Analyst Decision
- ACLS Strong Buy
- BHC Hold
- Analyst Count
- ACLS 6
- BHC 4
- Target Price
- ACLS $169.80
- BHC $7.25
- AVG Volume (30 Days)
- ACLS 603.1K
- BHC 1.4M
- Earning Date
- ACLS 02-05-2025
- BHC 10-30-2024
- Dividend Yield
- ACLS N/A
- BHC N/A
- EPS Growth
- ACLS N/A
- BHC N/A
- EPS
- ACLS 6.77
- BHC N/A
- Revenue
- ACLS $1,075,736,000.00
- BHC $9,474,000,000.00
- Revenue This Year
- ACLS N/A
- BHC $10.68
- Revenue Next Year
- ACLS N/A
- BHC $3.66
- P/E Ratio
- ACLS $10.27
- BHC N/A
- Revenue Growth
- ACLS N/A
- BHC 10.91
- 52 Week Low
- ACLS $68.31
- BHC $3.96
- 52 Week High
- ACLS $158.61
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- ACLS 32.30
- BHC 37.99
- Support Level
- ACLS $74.00
- BHC $7.42
- Resistance Level
- ACLS $77.22
- BHC $7.79
- Average True Range (ATR)
- ACLS 2.89
- BHC 0.28
- MACD
- ACLS -0.06
- BHC -0.06
- Stochastic Oscillator
- ACLS 12.93
- BHC 8.40
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provide aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Geographically, the group has a business presence in North America, Asia Pacific and Europe, of which key revenue is derived from the Asia Pacific.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.